October 6, 2020
US tech giant NVIDIA has announced plans to build the UK’s most powerful supercomputer, to help healthcare researchers.
The Cambridge-1 supercomputer is expected to come online by the end of the year and is intended for artificial intelligence (AI) research into medical challenges, including those presented by COVID-19.
Speaking at his GPU Technology Conference keynote, NVIDIA founder and CEO,...
July 19, 2018
Earnings reports shared by neurostimulation and digital medicine company NeuroMetrix during a Q2 investors’ call showed a slight drop in total revenue as the company is preparing to place its marketing weight behind the launch of its updated wearable pain relief product, Quell. However, the company remained profitable during the quarter thanks to sales of its other product, DPNCheck.
Dr. Shai N....
August 3, 2017
GlaxoSmithKline has made a hire signaling its commitment to digital health. Karenann Terrell, former Chief Information Officer at Walmart, will start at GSK in the newly created role of Chief Digital and Technology Officer.
“The impact of technology on the healthcare industry is accelerating and requires us to rethink our approach,” CEO Emma Walmsley said in a statement. “As a member of the...
November 7, 2016
Madison, Wisconsin-based Propeller Health, maker of several smart inhaler sensors and companion apps, has received FDA 510(k) clearance for its latest offering – a sensor that works with GlaxoSmithKline’s Ellipta inhaler.
This marks the company’s eighth FDA clearance, and was born out of a partnership the company struck up with GSK last December. Given Propeller's growing familiarity with the...
October 12, 2016
3M Health Information Systems as entered an agreement with Verily (formerly Google Life Sciences) to develop new population health measurement technology. The joint platform will work to assess quality performance data across healthcare delivery systems and patient populations, providing actionable insights that can be used to make improvements in healthcare quality and cost. The platform will...
October 6, 2016
Watching a weather app to see if a cold front is coming in has taken on a new meaning: The Cold and Flu Tracker app, where people can get updates on cold and flu activity at a hyperlocal level, is now available to users thanks to a partnership with GlaxoSmithKline Consumer Healthcare’s Theraflu and the Weather Company.
Beyond mixing sickness with weather, the app is also part of GSK’s overall...
September 23, 2016
When Apple announced ResearchKit in March 2015, and unveiled the first five apps to test-drive the company’s new approach to clinical research, the announcement made a big splash. And indeed, in the weeks following, those apps posted incredible recruitment figures: for instance, Parkinson’s emPower study saw 5,500 sign-ups by day two and ended up with more than 18,000 participants.
July 18, 2016
GlaxoSmithKline has launched the ResearchKit app that it told Buzzfeed it was working on more than a year ago, making it the first pharma company to get a ResearchKit study off the ground. The study is called PARADE, which the company says stands for Patient Rheumatoid Arthritis Data in the Real World.
"We are the first in our industry to use Apple’s ResearchKit as part of our research, this time...
March 23, 2016
Propeller Health and Boehringer Ingelheim announced a new commercial partnership. Under the partnership, COPD and asthma patients using Boehringer's Respimat inhaler will have the opportunity to enroll in a program at select health systems that will monitor their adherence via a Propeller sensor and improve their engagement in their health.
"So far we have developed a popular Bluetooth-enabled...
March 9, 2016
Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program.
2Morrow’s smoking cessation app, called SmartQuit, is based on acceptance and commitment therapy, or an ACT-based program, that "focuses on increasing one’s willingness to accept the physical, mental...